Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 3
2009 3
2010 2
2011 1
2012 3
2013 3
2014 2
2015 1
2016 1
2018 2
2019 4
2020 3
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body.
Pan C, Schoppe O, Parra-Damas A, Cai R, Todorov MI, Gondi G, von Neubeck B, Böğürcü-Seidel N, Seidel S, Sleiman K, Veltkamp C, Förstera B, Mai H, Rong Z, Trompak O, Ghasemigharagoz A, Reimer MA, Cuesta AM, Coronel J, Jeremias I, Saur D, Acker-Palmer A, Acker T, Garvalov BK, Menze B, Zeidler R, Ertürk A. Pan C, et al. Among authors: cuesta am. Cell. 2019 Dec 12;179(7):1661-1676.e19. doi: 10.1016/j.cell.2019.11.013. Cell. 2019. PMID: 31835038 Free PMC article.
C3G Protein, a New Player in Glioblastoma.
Manzano S, Gutierrez-Uzquiza A, Bragado P, Cuesta AM, Guerrero C, Porras A. Manzano S, et al. Among authors: cuesta am. Int J Mol Sci. 2021 Sep 16;22(18):10018. doi: 10.3390/ijms221810018. Int J Mol Sci. 2021. PMID: 34576182 Free PMC article. Review.
Multivalent antibodies: when design surpasses evolution.
Cuesta AM, Sainz-Pastor N, Bonet J, Oliva B, Alvarez-Vallina L. Cuesta AM, et al. Trends Biotechnol. 2010 Jul;28(7):355-62. doi: 10.1016/j.tibtech.2010.03.007. Epub 2010 May 4. Trends Biotechnol. 2010. PMID: 20447706 Review.
Antibody engineering: facing new challenges in cancer therapy.
Sanz L, Cuesta AM, Compte M, Alvarez-Vallina L. Sanz L, et al. Among authors: cuesta am. Acta Pharmacol Sin. 2005 Jun;26(6):641-8. doi: 10.1111/j.1745-7254.2005.00135.x. Acta Pharmacol Sin. 2005. PMID: 15916728 Review.
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.
de Rojas-P I, Albiñana V, Taranets L, Recio-Poveda L, Cuesta AM, Popov N, Kronenberger T, Botella LM. de Rojas-P I, et al. Among authors: cuesta am. Cells. 2021 Sep 4;10(9):2313. doi: 10.3390/cells10092313. Cells. 2021. PMID: 34571962 Free PMC article.
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.
Compte M, Harwood SL, Muñoz IG, Navarro R, Zonca M, Perez-Chacon G, Erce-Llamazares A, Merino N, Tapia-Galisteo A, Cuesta AM, Mikkelsen K, Caleiras E, Nuñez-Prado N, Aznar MA, Lykkemark S, Martínez-Torrecuadrada J, Melero I, Blanco FJ, Bernardino de la Serna J, Zapata JM, Sanz L, Alvarez-Vallina L. Compte M, et al. Among authors: cuesta am. Nat Commun. 2018 Nov 15;9(1):4809. doi: 10.1038/s41467-018-07195-w. Nat Commun. 2018. PMID: 30442944 Free PMC article.
Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease.
Albiñana V, Gallardo-Vara E, de Rojas-P I, Recio-Poveda L, Aguado T, Canto-Cano A, Aguirre DT, Serra MM, González-Peramato P, Martínez-Piñeiro L, Cuesta AM, Botella LM. Albiñana V, et al. Among authors: cuesta am. J Clin Med. 2020 Aug 25;9(9):2740. doi: 10.3390/jcm9092740. J Clin Med. 2020. PMID: 32854260 Free PMC article.
29 results